Constantinos Zamboglou (@czamboglou) 's Twitter Profile
Constantinos Zamboglou

@czamboglou

Father of 3 | Vice Medical Director @goc_cy | Research group leader @Uniklinik_Fr | GU RadOnc | my views

ID: 1530641807444516866

calendar_today28-05-2022 20:07:09

292 Tweet

541 Followers

443 Following

Constantinos Zamboglou (@czamboglou) 's Twitter Profile Photo

Excellent talk by Giulia Marvaso on the Radiosa trial. Conclusion of this phase II RCTs: SBRT should be performed with ADT and not alone for metachronous mHSPC

Excellent talk by <a href="/GiuliaMarvaso84/">Giulia Marvaso</a> on the Radiosa trial. Conclusion of this phase II RCTs: SBRT should be performed with ADT and not alone for metachronous mHSPC
prof. Barbara Jereczek-Fossa (@barbarajereczek) 's Twitter Profile Photo

I am deeply grateful for the incredible support I have received. I am committed to serving @ESTRO and radiation oncology community for the best of our patients. Thank you

I am deeply grateful for the incredible support I have received. I am committed to serving @ESTRO and radiation oncology community for the best of our patients. Thank you
Constantinos Zamboglou (@czamboglou) 's Twitter Profile Photo

This weekend, we had the pleasure and honour to have Markus Graefen and his brother Oliver as guests at the German Oncology Center! We had great discussions on PCa management as well as quality assurance and are deeply impressed by the „Martini way“ of performing medicine.

This weekend, we had the pleasure and honour to have <a href="/MarkusGraefen/">Markus Graefen</a> and his brother Oliver as guests at the <a href="/goc_cy/">German Oncology Center</a>! We had great discussions on PCa management as well as quality assurance and are deeply impressed by the „Martini way“ of performing medicine.
Vedang Murthy (@vedangmurthy) 's Twitter Profile Photo

Poll for #radonc #prostatecancer #oligometastatic For synchronous OligoM HSPC (on PSMA of course), what is your RT practice with ADT+/- ARTA If you do 1 in practice, and want to collaborate further, please get in touch!

ESTRO (@estro_rt) 's Twitter Profile Photo

Read the report of this phase II multicentre trial, which was presented at #ESTRO24 and explores the impact of adjuvant #radiotherapy for high-risk, muscle-invasive #bladdercancer in the #immunotherapy era. 👉 bit.ly/3VIewzz #radonc

Read the report of this phase II multicentre trial, which was presented at #ESTRO24 and explores the impact of adjuvant #radiotherapy for high-risk, muscle-invasive #bladdercancer in the #immunotherapy era.
👉 bit.ly/3VIewzz
#radonc
Sophia Kamran, MD (@sophia_kamran) 's Twitter Profile Photo

I don't know how she does it all, and with such grace! Her commitment is unflappable, she will do great things for the radonc community. So, in the end VOTE FOR Neha Vapiwala FOR ASTRO PRESIDENT!

Prostate Cancer Foundation (@pcfnews) 's Twitter Profile Photo

New study shows PSMA-PET-guided salvage radiotherapy improves short- and mid-term outcomes for recurrent prostate cancer after surgery. Constantinos Zamboglou & Zach Klaassen discuss on UroToday.com: tinyurl.com/prax39eb

New study shows PSMA-PET-guided salvage radiotherapy improves short- and mid-term outcomes for recurrent prostate cancer after surgery. 

<a href="/CZamboglou/">Constantinos Zamboglou</a> &amp; <a href="/zklaassen_md/">Zach Klaassen</a> discuss on <a href="/urotoday/">UroToday.com</a>: tinyurl.com/prax39eb
Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial out in European Urology sciencedirect.com/science/articl… The PACE-A trial is a phase 3⃣ randomized study comparing patient-reported outcomes between

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial out in <a href="/EUplatinum/">European Urology</a>

sciencedirect.com/science/articl…

The PACE-A trial is a phase 3⃣ randomized study comparing patient-reported outcomes between